Cortical pseudolaminar necrosis
Cortical pseudolaminar necrosis is a pathological condition characterized by the band-like necrosis of neurons in the cerebral cortex. This condition is typically observed in the aftermath of events that lead to a significant reduction in cerebral blood flow, such as ischemic stroke, hypoxic-ischemic encephalopathy, and status epilepticus. The term "pseudolaminar" refers to the appearance of necrosis in layers of the cortex that resemble the normal laminar (layered) structure of the cortex, although the necrosis does not strictly follow these layers.
Etiology[edit]
Cortical pseudolaminar necrosis is primarily caused by conditions that lead to acute or chronic reductions in cerebral blood flow. The most common cause is an ischemic stroke, where a blockage in the cerebral arteries reduces blood flow to a portion of the brain. Other causes include cardiac arrest, leading to global cerebral hypoxia, and prolonged seizures (status epilepticus), which can increase metabolic demand and reduce effective blood flow to the brain.
Pathophysiology[edit]
The pathophysiology of cortical pseudolaminar necrosis involves a complex cascade of events triggered by reduced blood flow and oxygen delivery to the brain. This ischemic condition leads to energy failure, causing neurons to lose their ability to maintain ionic gradients across their membranes. The resultant influx of calcium ions into cells activates a series of enzymatic reactions that lead to cell death. Neurons in certain layers of the cortex are particularly vulnerable to ischemia, leading to the characteristic band-like pattern of necrosis.
Clinical Presentation[edit]
The clinical presentation of cortical pseudolaminar necrosis can vary widely depending on the underlying cause and the extent of brain involvement. Symptoms may include neurological deficits such as weakness, aphasia, visual field deficits, and cognitive impairment. In severe cases, patients may present with coma or profound neurological impairment.
Diagnosis[edit]
Diagnosis of cortical pseudolaminar necrosis is primarily based on imaging studies. Magnetic resonance imaging (MRI) is the modality of choice, with T1-weighted images showing hyperintense signals in the affected cortical regions. Diffusion-weighted imaging (DWI) can also reveal changes in the early stages of the condition. In some cases, computed tomography (CT) scans may show hypodense areas in the cortex, although MRI is more sensitive and specific.
Treatment[edit]
Treatment of cortical pseudolaminar necrosis focuses on addressing the underlying cause and supporting affected individuals through rehabilitation. In the case of ischemic stroke, interventions may include thrombolytic therapy to restore blood flow, while supportive care is essential for conditions like hypoxic-ischemic encephalopathy. Rehabilitation efforts aim to maximize recovery of function and may involve physical therapy, occupational therapy, and speech therapy.
Prognosis[edit]
The prognosis for individuals with cortical pseudolaminar necrosis varies widely and depends on the extent of brain damage and the success of interventions to address the underlying cause. Some individuals may experience significant recovery, while others may have permanent neurological deficits.
See Also[edit]
-
Cortical pseudolaminar necrosis - LFB - very low magnification
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
